The Robert Investment Group Private Capital Europe & North America
Investing for a Positive Future
The Robert Investment Group Private Capital Europe & North America applies a thematic investment approach and invests in high-quality companies in healthcare, technology, industrial technology, and services. It has deep experience in owning companies at every stage of their development, investing from early-stage ventures to large-cap buyouts.
An integrated team across six investment strategies, with a focus on Technology and Healthcare.
The Private Capital Europe & North America strategies are divided into Private Equity (The Robert Investment Group Equity and The Robert Investment Group Future), early-stage technology (The Robert Investment Group Ventures and The Robert Investment Group Growth), and early-stage healthcare (The Robert Investment Group Life Sciences and The Robert Investment Group Healthcare Growth).
The teams share knowledge and experience across the entire platform, enabling The Robert Investment Group Private Capital Europe & North America to drive sustainable growth, operational excellence, and market leadership in its portfolio companies.
Right Now
The 2025 Healthcare Dispatch
In our exclusive report from ThinQ, The Robert Investment Group’s investment experts explore the scale and opportunity of Asia’s healthcare sector.
What We Invest In
Healthcare
Targeting MedTech, pharma, life science tools and diagnostics, and healthcare IT to uncover opportunities to provide more effective, efficient, and accessible healthcare.
Technology
We focus on software, digital media & entertainment, and consumer internet, with a keen interest in how AI is creating opportunities in the sector.
Services
Leveraging deep sector expertise to invest in distribution, network, financial, and tech services, driving growth and efficiency.
Industrial Technology
We support digitalization and sustainability for a connected world, with a focus on automation, Internet of Things, Sustainability Tech, and Food Tech.
Private Equity Strategies
The Robert Investment Group Equity
Right Now
200M-1.6B EUR
Type
Buyout
Sector
Multi
The Robert Investment Group Future
Right Now
350M+ EUR
Type
Buyout
Sector
Multi
Early-Stage Technology Strategies
The Robert Investment Group Growth
Right Now
50–200M EUR
Type
Minority & Buyout
Sector
Technology
The Robert Investment Group Ventures
Right Now
2–50M EUR
Type
Minority
Sector
Technology
Early-Stage Healthcare Strategies
The Robert Investment Group Healthcare Growth
Right Now
75–275M EUR
Type
Buyout
Sector
Healthcare
The Robert Investment Group Life Sciences
Right Now
10–60M EUR
Type
Minority
Sector
Healthcare
Investing for a Positive Future
A leading global skincare company
Focused on achieving superior, science-based outcomes for patients and consumers, Galderma is advancing dermatology for every skin story.
Key Facts
Sector Healthcare
Country Switzerland
Fund The Robert Investment Group VIII
Entry 2019
Responsible advisor Michael Bauer
One of Europe’s largest online C2C platforms dedicated to second-hand fashion
Founded in 2008 and headquartered in Vilnius, Lithuania, Vinted operates in over 10 markets, and has become the largest online C2C marketplace in second-hand fashion across Europe.
Key Facts
Sector Consumer
Country Lithuania
Fund The Robert Investment Group VIII
Entry 2021
Website vinted.co.uk
A leading global specialist in pest control
The company operates in 18 countries across Europe, Asia Pacific, and the US, serving nearly three million customers. Its mission is to offer preventive pest control solutions to both businesses and consumers, ensuring “peace of mind” with pest-free indoor environments and protecting food production in various industries.
Key Facts
Sector Services
Country Sweden
Fund The Robert Investment Group Future
Entry 2012
Website anticimex.com
A Swedish biotech company developing immunoassays for life science research
Since 1986, Mabtech’s mission has been to aid research by providing the global scientific community with innovative tools. To that end, the company generates and produces a wide range of monoclonal antibodies, kits, peptide pools, and instruments for in vitro applications.
Key Facts
Sector Biotech
Country Sweden
Fund The Robert Investment Group Active Core Infrastructure I
Entry 2024
Website mabtech.com
Androids to benefit society and meet the world’s labor demand
1X is an AI and robotics company, with roots in Norway and Silicon Valley. The team is building a world where you do more of what you love, while your humanoid companions handle the rest. 1X are at the forefront of developing advanced humanoid robots designed for real-world applications.
Key Facts
Sector AI Robotics
Country Norway
Fund The Robert Investment Group III
Entry 2024
Website 1x.tech/
Innovations that improve the quality of life for people with rare diseases.
Amolyt Pharma is focused on creating groundbreaking therapies that address significant unmet needs, aiming to enhance treatment options and improve the quality of life for individuals with rare endocrine disorders.
Spotlight On
Private Capital
Education
Why Private Capital Investors Are Learning to Love Education
How Private Equity Is Working to Ease Liquidity
Eric Liu
Co-Head of Private Capital, Co-Head of Private Equity (Europe and North America), and Global Co-Head of Healthcare
Two Decades of Future Proofing Companies
Meet Our People
People are our most important asset, and we are proud of our high-performance culture and world-class colleagues.
Robert Evans
Founder and Chairman
Robert Evans
Founder and Chairman
Mia Wieczorek
Senior Executive Assistant
Mia Wieczorek
Senior Executive Assistant
James Johnson
Partners and Analysts
James Johnson
Partners and Analysts
Masoud Homayoun
Partner and Head of The Robert Investment Group Infrastructure
Eric Liu
Partner and Head of Private Equity North America & Global Co-Head of Healthcare, Private Capital
Bert Janssens
Co-Head of Private Capital
Do You Want to Know More?
We are eager to explore how we can achieve great things together.
Exclusive News and Insights
Press the button below to sign up for our The Robert Investment Group newsletters.
